Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2013

Planlagt Fastgjort Låst Flyttet Genmab
190 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #66

    Nu skal vi også til at lære om tribody ...

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #67

      To achieve comparable effects, ~10- or 100-fold higher concentrations of 7D8 or rituximab had to be employed

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #68

        301 Moved Permanently

        favicon

        (www.nature.com)

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #69

          Although ~50 to 65% of B cells were depleted by the tribody, little reduction was observed with 7D8 and none with rituximab (!!!)

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #70

            A bispecific antibody was designed in the tribody format for redirecting CD16-positive effector cells against CD20-positive malignant B cells

            1 Reply Last reply
            0
            • G Offline
              G Offline
              gentogen
              wrote on sidst redigeret af
              #71

              Ikke at jeg forstår det, men det ser overbevisende ud ...

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #72

                PS, taget fra Solsens tidligere link

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #73

                  Tribody: http://www.biotecnol.com/technology/tribody-technology/

                  1 Reply Last reply
                  0
                  • R Offline
                    R Offline
                    Repsac
                    wrote on sidst redigeret af
                    #74

                    Hvis Winkler sælger, skal det så offentligtgøres?

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      deleted-user
                      wrote on sidst redigeret af
                      #75

                      ja det er en insiderhandel

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #76

                        Disease control of CLL with deletion 17p by monotherapy with a monoclonal antibody in the 6th line of treatment also highlights the potency of ofatumumab in this risk group

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #77

                          this is the first report on ofatumumab maintenance therapy, with still continuing response after 24 months.

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #78

                            Just a moment...

                            favicon

                            (onlinelibrary.wiley.com)

                            1 Reply Last reply
                            0
                            • investor1989I Offline
                              investor1989I Offline
                              investor1989
                              wrote on sidst redigeret af
                              #79

                              Arzerra maintaince CLL skulle være det vigtigste stuide

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #80

                                http://www.sibbing.com/blog/en/tag/daratumumab-en/ Bas har ikke den bedste effekt af dara

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #81

                                  Nej effekten aftager og det er trist. Spændende om der i protokollen åbnes mulighed for at øge dosis og i givet fald om det har effekt.

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #82

                                    Uanset hvad ville det være rart med nyt fra daratumumab - og ikke bare Jans ord for at alt går fint.

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #83

                                      Ikke alarmerende at et enkeltstående tilfælde ikke har så stor effekt selvom det er kedeligt for Bas - det er jo stadig monotrial. Vi ved fra Jan at fremtiden er combibehandlinger

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #84

                                        Enig Solsen - ingen grund til bekymring der. Det er stadig SD eller måske endda mPR. Man skal passe på at konkludere ret meget ud fra en enkelt patient.

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #85

                                          Hans sygehistorie taget i betragtning er det vel stadig en ganske god effekt fra et Dara synspunkt. Effekt og stabilitet ved ugentlige behandlinger og måske svag negativ effekt ved første 14 dages behandling. men selvfølgelig er det en meget svær situation som patient.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger